Lucid Diagnostics Inc. — Director's Dealing 2023

Feb 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2023-01-31

Reporting Person: Sparks Ronald M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-31	Employee stock option (right to buy)	$1.31	A	175000	Acquired	2033-01-31	Common stock (175000)	Direct

Footnotes

F1: One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023.